Metabolic Markers Demonstrate the Heterogeneity of Myosteatosis in Community-Dwelling Older Black Men from the Health ABC Study

Metabolic Markers Demonstrate the Heterogeneity of Myosteatosis in Community-Dwelling Older Black Men from the Health ABC Study

Myosteatosis is a complex condition, associated with aging and diverse pathological conditions (e.g., diabetes), that contributes to mobility disability. Improved characterization of myosteatosis is required to develop targeted interventions to maintain muscle health in aging. We first determined th...

Full description

Bibliographic Details
Main Authors:	Samaneh Farsijani, Megan M. Marron, Iva Miljkovic, Mary Elizabeth Baugh, Stephen B. Kritchevsky, Anne B. Newman
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Metabolites
Subjects:	myosteatosis metabolomics aging heterogeneity African American mobility
Online Access:	https://www.mdpi.com/2218-1989/11/4/224

Similar Items

Metabolites Associated with Vigor to Frailty Among Community-Dwelling Older Black Men
by: Megan M. Marron, et al.
Published: (2019-04-01)

Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer
by: Yerim Kim, et al.
Published: (2023-04-01)

The Impact of Myosteatosis Percentage on Short-Term Mortality in Patients with Septic Shock
by: June-sung Kim, et al.
Published: (2022-05-01)

The Clinical Significance of Myosteatosis in Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib
by: Min Kyu Kang, et al.
Published: (2024-01-01)

Quality Matters as Much as Quantity of Skeletal Muscle: Clinical Implications of Myosteatosis in Cardiometabolic Health
by: Hong-Kyu Kim, et al.
Published: (2021-12-01)

Sarcopenia and Myosteatosis Are Associated with Neutrophil to Lymphocyte Ratio but Not Glasgow Prognostic Score in Colorectal Cancer Patients
by: Raila Aro, et al.
Published: (2022-05-01)

Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19
by: Min-Kyu Kang, et al.
Published: (2022-09-01)

Psoriasis Is Associated With Myosteatosis but Not Sarcopenia: A Case-Control Study
by: Xiaomei Chen, et al.
Published: (2021-10-01)

Myosteatosis in NAFLD patients correlates with plasma Cathepsin D
by: Ding Lingling, et al.
Published: (2021-05-01)

Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta‐analysis
by: Chan Mi Lee, et al.
Published: (2020-10-01)

Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors
by: Mengchen Liu, et al.
Published: (2024-04-01)

Combined impact of myosteatosis and liver steatosis on prognosis in stage I–III colorectal cancer patients
by: Dong Hee Lee, et al.
Published: (2023-12-01)

Myosteatosis in a systemic inflammation‐dependent manner predicts favorable survival outcomes in locally advanced esophageal cancer
by: Camila T. B. Gabiatti, et al.
Published: (2019-11-01)

Sarcopenia and Myosteatosis as Prognostic Markers in Patients with Advanced Cholangiocarcinoma Undergoing Palliative Treatment
by: Markus S. Jördens, et al.
Published: (2021-09-01)

Sarcopenia and myosteatosis at presentation adversely affect survival after esophagectomy for esophageal cancer
by: Srpcic Matevz, et al.
Published: (2020-03-01)

Myosteatosis in the Context of Skeletal Muscle Function Deficit: An Interdisciplinary Workshop at the National Institute on Aging
by: Rosaly Correa-de-Araujo, et al.
Published: (2020-08-01)

A dynamic association between myosteatosis and liver stiffness: Results from a prospective interventional study in obese patients
by: Maxime Nachit, et al.
Published: (2021-08-01)

THE FEATURES OF PREOPERATIVE MYOPENIA, MYOSTEATOSIS, AND PHYSICAL FUNCTION IN JAPANESE PATIENTS WITH GASTROINTESTINAL CANCER: A CROSS-SECTIONAL STUDY
by: Noriatsu Tatematsu, et al.
Published: (2023-10-01)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
by: Hao Liu, et al.
Published: (2023-10-01)

Myosteatosis Is Not Associated with Complications or Survival in HCC Patients Undergoing Trans Arterial Embolization
by: Chiara Masetti, et al.
Published: (2022-12-01)

Myosteatosis rather than sarcopenia associates with non‐alcoholic steatohepatitis in non‐alcoholic fatty liver disease preclinical models
by: Maxime Nachit, et al.
Published: (2021-02-01)

SARC‐F as a screening tool to detect computed tomography‐based sarcopenia and myosteatosis among older adults with cancer
by: Daniel L. Hess, et al.
Published: (2023-11-01)

RORα–GABP–TFAM axis alleviates myosteatosis with fatty atrophy through reinforcement of mitochondrial capacity
by: Hyeon‐Ji Kim, et al.
Published: (2024-04-01)

The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort
by: Franziska Alexandra Meister, et al.
Published: (2022-01-01)

Impact of Baseline Muscle Mass and Myosteatosis on the Development of Early Toxicity During First-Line Chemotherapy in Patients With Initially Metastatic Pancreatic Cancer
by: Sun Hong, et al.
Published: (2022-05-01)

Myosteatosis and bone marrow adiposity are not associated among postmenopausal women with fragility fractures
by: Sammy Badr, et al.
Published: (2023-06-01)

Associations Between Lipoprotein Subfractions and Area and Density of Abdominal Muscle and Intermuscular Adipose Tissue: The Multi-Ethnic Study of Atherosclerosis
by: Megan M. Marron, et al.
Published: (2021-09-01)

The coexistence of myosteatosis and the creatinine/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery
by: Yan Liu, et al.
Published: (2024-04-01)

The Impact of Lower Extremity Skeletal Muscle Atrophy and Myosteatosis on Revascularization Outcomes in Patients with Peripheral Arterial Disease
by: Kirsten F. Ma, et al.
Published: (2021-08-01)

Association of Visceral Fat Obesity, Sarcopenia, and Myosteatosis with Non-Alcoholic Fatty Liver Disease without Obesity
by: Hong-Kyu Kim, et al.
Published: (2023-10-01)

Myosteatosis as an independent risk factor for mortality after kidney allograft transplantation: a retrospective cohort study
by: Antoine Morel, et al.
Published: (2022-02-01)

The role of recipient myosteatosis in graft and patient survival after deceased donor liver transplantation
by: Zoltan Czigany, et al.
Published: (2021-04-01)

A Retrospective Cohort Study of Myosteatosis and Quality of Life in Head and Neck Cancer Patients
by: Amy L. Shaver, et al.
Published: (2021-08-01)

Myosteatosis Significantly Predicts Persistent Dyspnea and Mobility Problems in COVID-19 Survivors
by: Rebecca De Lorenzo, et al.
Published: (2022-04-01)

Myosteatosis as a Prognostic Marker for Postoperative Mortality in Adult Patients Undergoing Surgery in General—A Systematic Review
by: Onno Emanuel den Os, et al.
Published: (2023-11-01)

Radiological assessment of skeletal muscle index and myosteatosis and their impact postoperative outcomes after liver transplantation
by: Petric Miha, et al.
Published: (2023-06-01)

Associations of OSA and Nocturnal Hypoxemia with Strength and Body Composition in Community Dwelling Middle Aged and Older Men
by: Stevens D, et al.
Published: (2020-11-01)

High prevalence of sarcopenia and myosteatosis in patients undergoing hemodialysis
by: Chen Fu, et al.
Published: (2023-03-01)

The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver Cirrhosis
by: Eleni Geladari, et al.
Published: (2023-05-01)

Are Sarcopenia and Myosteatosis in Elderly Patients with Pelvic Ring Injury Related to Mortality, Physical Functioning and Quality of Life?
by: Hester Banierink, et al.
Published: (2021-10-01)